Unlocking the secrets of COVID-19: a groundbreaking study reveals the intricate biomechanics behind the virus's evolution and spread.
Richard Feynman famously stated, "Everything that living things do can be understood in terms of the jigglings and wigglings of atoms." This week, Nature Nanotechnology features a groundbreaking study that sheds new light on the evolution of the coronavirus and its variants of concern by analyzing the behavior of atoms in the proteins at the interface between the virus and humans. The paper, titled "Single-molecule force stability of the SARS-CoV-2–ACE2 interface in variants-of-concern," is the result of an international collaborative effort among researchers from six universities across three countries.
Mechanical Stability of the Virus and Its Global Impact
The study introduces significant insights into the mechanical stability of the coronavirus, a key factor in its evolution into a global pandemic. The research team employed advanced computational simulations and magnetic tweezers technology to explore the biomechanical properties of biochemical bonds in the virus. Their findings reveal critical distinctions in the mechanical stability of various virus strains, highlighting how these differences contribute to the virus's aggressiveness and spread.
As the World Health Organization reports nearly 7 million deaths worldwide from COVID-19, with over 1 million in the United States alone, understanding these mechanics becomes crucial for developing effective interventions and treatments. The group emphasizes that comprehending the molecular intricacies of this pandemic is key to shaping our response to future viral outbreaks.
Key Contributions From Auburn University
Delving deeper into the study, the Auburn University team, led by Prof. Rafael C. Bernardi, Assistant Professor of Biophysics, along with Dr. Marcelo Melo and Dr. Priscila Gomes, played a pivotal role in the research by leveraging powerful computational analysis. Utilizing NVIDIA HGX-A100 nodes for GPU computing, their work was essential in unraveling complex aspects of the virus's behavior.
Prof. Bernardi, an NSF Career Award recipient, collaborated closely with Prof. Gaub from LMU, Germany, and Prof. Lipfert from Utrecht University, The Netherlands. Their collective expertise spanned various fields, culminating in a comprehensive understanding of the SARS-CoV-2 virulence factor. Their research demonstrates that the equilibrium binding affinity and mechanical stability of the virus–human interface are not always correlated, a finding crucial for comprehending the dynamics of viral spread and evolution.
Innovative Techniques and Findings on Virus Strains
Additionally, the team's use of magnetic tweezers to study the force-stability and bond kinetics of the SARS-CoV-2:ACE2 interface in various virus strains provides new perspectives on predicting mutations and adjusting therapeutic strategies. The methodology is unique because it measures how strongly the virus binds to the ACE2 receptor, a key entry point into human cells, under conditions that mimic the human respiratory tract.
The group found that while all the major COVID-19 variants (like Alpha, Beta, Gamma, Delta, and Omicron) bind more strongly to human cells than the original virus, the Alpha variant is particularly stable in its binding. This might explain why it spread so quickly in populations without prior immunity to COVID-19. The results also suggest that other variants, like Beta and Gamma, evolved in a way that helps them evade some immune responses, which might give them an advantage in areas where people have some immunity, either from previous infections or vaccinations.
Implications for Understanding and Responding to Variants
Interestingly, the Delta and Omicron variants, which became dominant worldwide, show traits that help them escape immune defenses and possibly spread more easily. However, they don't necessarily bind more strongly than other variants. Prof. Bernardi says that "This research is important because it helps us understand why some COVID-19 variants spread more quickly than others. By studying the virus's binding mechanism, we can predict which variants might become more prevalent and prepare better responses to them."
This research emphasizes the importance of biomechanics in understanding viral pathogenesis and opens new avenues for scientific investigation into viral evolution and therapeutic development. It stands as a testament to the collaborative nature of scientific research in addressing significant health challenges.
Reference: "Single-molecule force stability of the SARS-CoV-2–ACE2 interface in variants-of-concern" by Magnus S. Bauer, Sophia Gruber, Adina Hausch, Marcelo C. R. Melo, Priscila S. F. C. Gomes, Thomas Nicolaus, Lukas F. Milles, Hermann E. Gaub, Rafael C. Bernardi and Jan Lipfert, 27 November 2023, Nature Nanotechnology.
DOI: 10.1038/s41565-023-01536-7
News
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
